Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
1998-09-03
Original market date: See footnote 1
1992-12-31
Product name:
LACTATED RINGER'S INJECTION USP
DIN:
01931636
Product Monograph/Veterinary Labelling:
Date:
2020-09-15
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
B. BRAUN MEDICAL INC
824 Twelfth Avenue
Bethlehem
Pennsylvania
United States
18018
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
4
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
40:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
B05BB01 ELECTROLYTES
Active ingredient group (AIG) number:See footnote5
0400132001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| CALCIUM CHLORIDE | 20 MG / 100 ML |
| POTASSIUM CHLORIDE | 30 MG / 100 ML |
| SODIUM CHLORIDE | 600 MG / 100 ML |
| SODIUM LACTATE | 310 MG / 100 ML |